G. Rueedi

发表

Different Resistance Mechanisms for Cadazolid and Linezolid in Clostridium difficile Found by Whole-Genome Sequencing Analysis

P. Caspers, D. Ritz, H. Locher, 2017, Antimicrobial Agents and Chemotherapy.

Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic

P. Caspers, D. Boehringer, M. Leibundgut, 2019, Scientific Reports.

Electrophile, Substrate Functionality, and Catalyst Effects in the Synthesis of α‐Mono and Di‐Substituted Benzylamines via Visible‐Light Photoredox Catalysis in Flow

S. Richard-Bildstein, G. Vilé, G. Rueedi, 2018, ChemCatChem.

Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

D. Ritz, H. Locher, P. Seiler, 2017, Journal of medicinal chemistry.

Optimization of LpxC inhibitor lead compounds focusing on efficacy and formulation for high dose intravenous administration.

D. Ritz, R. Lange, S. Diethelm, 2019, Journal of medicinal chemistry.

Synthesis and Structure‐Activity Relationship of Xenocoumacin 1 and Analogues as Inhibitors of Ribosomal Protein Synthesis

P. Caspers, D. Ritz, G. Rueedi, 2020, ChemMedChem.

Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents.

L. Prade, D. Ritz, P. Seiler, 2017, Journal of medicinal chemistry.

Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.

Wolfgang Keck, Christopher Kohl, Daniel Ritz, 2013, Journal of medicinal chemistry.

Total Synthesis and Biological Evaluation of the Glycosylated Macrocyclic Antibiotic Mangrolide A

P. Caspers, K. Gademann, D. Ritz, 2018, Angewandte Chemie.

Total Synthesis and Biological Evaluation of the Glycosylated Macrocyclic Antibiotic Mangrolide A.

P. Caspers, K. Gademann, D. Ritz, 2018, Angewandte Chemie.

Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic

P. Caspers, D. Boehringer, M. Leibundgut, 2019, Scientific reports.

Discovery of Novel Inhibitors of LpxC Displaying Potent In Vitro Activity against Gram-Negative Bacteria.

D. Ritz, M. Wicki, A. Mac Sweeney, 2019, Journal of medicinal chemistry.

Novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram positive activity and improved safety profile.

D. Ritz, H. Locher, P. Seiler, 2015, Journal of medicinal chemistry.